Catecholamine Metabolism in Paraganglioma and Pheochromocytoma: Similar Tumors in Different Sites?

• Eric Grouzmann,

  Affiliation Service of Biomedicine, Catecholamine and Peptides Laboratory, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

  ⨯
• Oliver Tschopp,

  Affiliation Division of Endocrinology, Diabetes and Metabolism, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Frédéric Triponez,

  Affiliation Department of Thoracic and Endocrine Surgery, University Hospital Geneva (HUG), Geneva, Switzerland

  ⨯
• Maurice Matter,

  Affiliation Division of Visceral Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

  ⨯
• Stefan Bilz,

  Affiliation Clinic for Endocrinology, Diabetes, Bone disease and Metabolism, KantonsSpital St. Gallen, St. Gallen, Switzerland

  ⨯
• Michael Brändle,

  Affiliation Clinic for Endocrinology, Diabetes, Bone disease and Metabolism, KantonsSpital St. Gallen, St. Gallen, Switzerland

  ⨯
• Tilman Drechser,

  Affiliation Clinic for Endocrinology, Diabetes, Bone disease and Metabolism, KantonsSpital St. Gallen, St. Gallen, Switzerland

  ⨯
• Sarah Sigrist,

  Affiliation Clinic for Endocrinology, Diabetes, Bone disease and Metabolism, KantonsSpital St. Gallen, St. Gallen, Switzerland

  ⨯
• Henryk Zulewski,

  Affiliation Division for Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland

  ⨯
• Christoph Henzen,

  Affiliation Division of Endocrinology and Diabetes, KantonsSpital Luzern, Luzern, Switzerland

  ⨯
• Stefan Fischli,

  Affiliation Division of Endocrinology and Diabetes, KantonsSpital Luzern, Luzern, Switzerland

  ⨯
• Karim Abid

  * E-mail: Karim-alexandre.abid@chuv.ch

  Affiliation Service of Biomedicine, Catecholamine and Peptides Laboratory, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

  ⨯